Astra Values Entrepreneurial Spirit, Keeps R&D “Armies” Away From CAT
AstraZeneca seeks to preserve the entrepreneurial spirit of its acquisitions by giving them the opportunity to operate differently. "Our strategy is ... to bring them into the AstraZeneca family, but make sure they've got the opportunity to operate differently," CEO David Brennan said during AstraZeneca's fourth quarter earnings call Feb. 1
You may also be interested in...
AstraZeneca's focus on improving manufacturing efficiencies, on the heels of similar moves by Merck and Pfizer, may signal that manufacturing is the next target for industry cost-cutting initiatives
Big pharma appears increasingly comfortable giving acquired companies operational independence
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011